Stéphanie Corgnac

2.1k total citations · 1 hit paper
28 papers, 1.3k citations indexed

About

Stéphanie Corgnac is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Stéphanie Corgnac has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 20 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Stéphanie Corgnac's work include Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (15 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Stéphanie Corgnac is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (15 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Stéphanie Corgnac collaborates with scholars based in France, Switzerland and United States. Stéphanie Corgnac's co-authors include Fathia Mami‐Chouaib, Yasemin Virk, Aurélie Durgeau, Ines Malenica, Marie Boutet, Éric Tartour, Charlotte Blanc, Sophie Hans, Clémence Granier and Gwendoline Gros and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Stéphanie Corgnac

25 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy

2018 372 citations Aurélie Durgeau, Yasemin Virk et al. Frontiers in Immunology profile →

Peers

Countries citing papers authored by Stéphanie Corgnac

Since Specialization

Citations

This map shows the geographic impact of Stéphanie Corgnac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Corgnac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Corgnac more than expected).

Fields of papers citing papers by Stéphanie Corgnac

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie Corgnac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Corgnac. The network helps show where Stéphanie Corgnac may publish in the future.

Co-authorship network of co-authors of Stéphanie Corgnac

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie Corgnac. A scholar is included among the top collaborators of Stéphanie Corgnac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie Corgnac. Stéphanie Corgnac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Different tumour-resident memory T-cell subsets regulate responses to anti-PD-1 and anti-CTLA-4 cancer immunotherapies 2025 ·Nature Communications ·(unknown), (unknown), Édouard Auclin, Julien Adam, Sébastien Mella, Milena Hasan, Éric Tartour, Caroline Robert, Stéphanie Corgnac, Fathia Mami‐Chouaib	0
2	TGF-β and IL-12 conversely orchestrate the formation of CD103+ CD8 tumor-resident memory T cells to regulate response to therapeutic cancer vaccine 2025 ·iScience ·Stéphanie Corgnac, (unknown), Carla Gentile, (unknown), (unknown), (unknown), Fathia Mami‐Chouaib	0
3	Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy 2023 ·Frontiers in Immunology ·(unknown), (unknown), Fathia Mami‐Chouaib, Stéphanie Corgnac	29
4	Cancer stem-like cells evade CD8⁺CD103⁺ tumor-resident memory T (T_RM) lymphocytes by initiating an epithelial-to-mesenchymal transition program in a human lung tumor model 2022 ·Journal for ImmunoTherapy of Cancer ·Stéphanie Corgnac, (unknown), Gwendoline Gros, (unknown), Stéphane Terry, Salem Chouaı̈b, Marc Deloger, Fathia Mami‐Chouaib	27
5	Vaccine Therapy in Non-Small Cell Lung Cancer 2022 ·Vaccines ·Miguel García-Pardo, (unknown), Ines Malenica, Stéphanie Corgnac, Cristina Teixidó, Laura Mezquita	13
6	When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak 2021 ·Frontiers in Immunology ·Yassine Taoufik, Marie-Ghislaine de Goër de Herve, Stéphanie Corgnac, Antoine Dürrbach, Fathia Mami‐Chouaib	6
7	Isolation of tumor-resident CD8+ T cells from human lung tumors 2021 ·STAR Protocols ·Stéphanie Corgnac, Yann Lécluse, Fathia Mami‐Chouaib	5
8	Integrin-αV-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade 2021 ·Nature Communications ·Ines Malenica, Julien Adam, Stéphanie Corgnac, Laura Mezquita, Édouard Auclin, (unknown), (unknown), Gwendoline Gros, Vincent de Montpréville, David Planchard, Nathalie Théret, Benjamin Besse, Fathia Mami‐Chouaib	46
9	AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity 2019 ·Cancer Immunology Research ·Stéphane Terry, (unknown), Agnete S. T. Engelsen, Stéphanie Buart, Philippe Dessen, Stéphanie Corgnac, (unknown), Guillaume Meurice, Gro Gausdal, Véronique Baud, (unknown), (unknown), Jean Paul Thiery, Fathia Mami‐Chouaib, Salem Chouaı̈b	61
10	Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1 2019 ·Nature Communications ·Marine Leclerc, (unknown), Gwendoline Gros, Stéphanie Corgnac, Vincent de Montpréville, Pierre Validire, Georges Bismuth, Fathia Mami‐Chouaib	105
11	Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours 2018 ·Nature Communications ·Aurélie Durgeau, Yasemin Virk, Gwendoline Gros, (unknown), Stéphanie Corgnac, (unknown), Jérôme Salmon, Julien Adam, Vincent de Montpréville, Pierre Validire, Soldano Ferrone, Salem Chouaı̈b, Alexander Eggermont, Jean‐Charles Soria, François A. Lemonnier, Éric Tartour, Nathalie Chaput, Benjamin Besse, Fathia Mami‐Chouaib	21
12	Cancer Immunotherapy 2017 (Paris, France). Progress and challenges 2018 ·Bulletin du Cancer ·(unknown), Stéphane Terry, Stéphanie Corgnac, Agnete S. T. Engelsen	1
13	Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy breakdown → 2018 ·Frontiers in Immunology ·Aurélie Durgeau, Yasemin Virk, Stéphanie Corgnac, Fathia Mami‐Chouaib	372
14	Resident memory T cells, critical components in tumor immunology 2018 ·Journal for ImmunoTherapy of Cancer ·Fathia Mami‐Chouaib, Charlotte Blanc, Stéphanie Corgnac, Sophie Hans, Ines Malenica, Clémence Granier, (unknown), Éric Tartour	219
15	Paxillin Binding to the Cytoplasmic Domain of CD103 Promotes Cell Adhesion and Effector Functions for CD8+ Resident Memory T Cells in Tumors 2017 ·Cancer Research ·(unknown), Stéphanie Corgnac, Marie Boutet, Gwendoline Gros, Pierre Validire, Georges Bismuth, Fathia Mami‐Chouaib	41
16	iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine 2014 ·Journal for ImmunoTherapy of Cancer ·Stéphanie Corgnac, Rachel Perret, Lianjun Zhang, Jean‐Pierre Mach, Pedro Romero, Alena Donda	14
17	Adjuvants That Improve the Ratio of Antigen-Specific Effector to Regulatory T Cells Enhance Tumor Immunity 2013 ·Cancer Research ·Rachel Perret, Sophie Sierro, Natalia K. Botelho, Stéphanie Corgnac, Alena Donda, Pedro Romero	72
18	CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses 2012 ·Cancer Immunology Immunotherapy ·Stéphanie Corgnac, Rachel Perret, Laurent Derré, Lianjun Zhang, (unknown), Maurice Zauderer, Daniel E. Speiser, Jean‐Pierre Mach, Pedro Romero, Alena Donda	30
19	Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice 2011 ·Breast Cancer Research ·Maha Zohra Ladjemi, Thierry Chardès, Stéphanie Corgnac, Véronique Garambois, (unknown), Bruno Robert, Caroline Mollévi, (unknown), (unknown), Jean‐Pierre Pouget, André Pèlegrin, Isabelle Navarro‐Teulon	16
20	A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy 2009 ·Vaccine ·Nidia Alvarez-Rueda, Maha Zohra Ladjemi, Ghislaine Béhar, Stéphanie Corgnac, Martine Pugnière, Françoise Roquet, (unknown), Daniel Baty, André Pèlegrin, Isabelle Navarro‐Teulon	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact